Paid Clinical Trials in Bakersfield, CA
As of July 2026, 67 paid clinical trials are recruiting in Bakersfield, California. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Bakersfield offers studies at sites including AIS Cancer Center at San Joaquin Community Hospital for conditions such as Breast Cancer, Asthma, Neovascular Age-Related Macular Degeneration (nAMD), AMD. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Bakersfield
Filter results
0 clinical trials
·Clear filters·↓ Download CSVTop Research Study Locations in Bakersfield
Researchers run research studies in Bakersfield, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| AIS Cancer Center at San Joaquin Community Hospital | Breast Cancer, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | 10 |
| California Retina Consultants | AMD, Age - Related Macular Degeneration (AMD), DME | 6 |
| Michael G Oefelein Clinical Trials | Benign Prostatic Hyperplasia, Bladder (Urothelial, Transitional Cell) Cancer, NMIBC | 6 |
| CBCC Global Research | Colorectal Neoplasms | 2 |
| California Retina Consultants (Bakersfield) | Macular Edema Secondary to Inflammation | 2 |
| Comprehensive Blood and Cancer Center | Breast Cancer, Breast Cancer Metastatic, Breast Neoplasm | 2 |
| GSK Investigational Site | Asthma, HIV Infections | 2 |
| Michael G Oefelein, MD Clinical Trials | High-Risk Non-Muscle-Invasive Bladder Cancer, Intermediate Risk Non-Muscle Invasive Bladder Cancer | 2 |
| Michael Oefelein Clinical Trials | Bladder (Urothelial, Transitional Cell) Cancer, Non-Muscle Invasive Bladder Carcinoma, Non-muscle Invasive Bladder Cancer | 2 |
| Kern Research, Inc. | Chronic Inducible Urticaria, Cold Urticaria, Cold-Induced Urticaria | 2 |
| ADARx Clinical Site | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Adventist Health - Bakersfield | Breast Cancer | 1 |
| Adventist Health/AIS Cancer Center | Breast Neoplasms, Carcinoma, Ductal, Breast, Receptors, Estrogen (for ER-positive Requirement) | 1 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Bakersfield VA Clinic, VA Greater Los Angeles Healthcare System | Burnout, Burnout Syndrome | 1 |
| CBCC Global Research - Comprehensive Blood & Cancer Center | Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer | 1 |
| CBCC Global Research, Inc. | Non-small Cell Lung Cancer | 1 |
| California Retina Consultants (CRC) | Neovascular Age-Related Macular Degeneration (nAMD) | 1 |
| California Retina Consultants (CRC) - Bakersfield Office | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| California Retina Consultants - Bakersfield | AMD, CNV, Wet Age-related Macular Degeneration | 1 |
| Centre for Neuro Skills | Traumatic Brain Injury | 1 |
| Comprehensive Blood & Cancer Center | Breast Cancer | 1 |
| Comprehensive Blood & Cancer Center [Bakersfield, CA] | Hematologic Malignancies, Solid Tumors | 1 |
| Empire Eye & Laser Center | Tilt and Decentration | 1 |
| Empire Eye and Laser Center | Contrast Sensitivity, Dysphotopsia, Posterior Capsule Opacification | 1 |
Active & Upcoming Studies in Bakersfield (2026)
Recruiting trials in Bakersfield grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (27 active studies)
- A Phase 1 Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC · Phase 1 · UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd.
- Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer · Phase 3 · Protara Therapeutics
Eye & vision (11 active studies)
- Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study · Phase 3 · Ocular Therapeutix, Inc.
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) · Phase 3 · Adverum Biotechnologies, Inc.
Vaccines (1 active study)
HIV / STI (1 active study)
- A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) · Phase 2 · ViiV Healthcare
Mental health & behavior (1 active study)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Diabetes & metabolic (1 active study)
Cardiovascular (1 active study)
Common conditions studied in Bakersfield
- Breast Cancer (5 active studies)
- Asthma (3 active studies)
- Neovascular Age-Related Macular Degeneration (nAMD) (3 active studies)
- AMD (2 active studies)
- Bladder (Urothelial, Transitional Cell) Cancer (2 active studies)
- Chronic Spontaneous Urticaria (2 active studies)
Leading research sponsors in Bakersfield
- Merck Sharp & Dohme LLC
- NRG Oncology
- AstraZeneca
- AbbVie
- Alliance for Clinical Trials in Oncology
Frequently asked questions
How many paid clinical trials are currently recruiting in Bakersfield?
There are approximately 67 recruiting clinical trials in Bakersfield, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Bakersfield pay participants?
Most recruiting trials in Bakersfield compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Bakersfield?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Bakersfield?
The most common conditions under active study in Bakersfield include Breast Cancer (5), Asthma (3), Neovascular Age-Related Macular Degeneration (nAMD) (3), AMD (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Bakersfield?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Bakersfield on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Bakersfield?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Bakersfield?
Recruiting research sites in Bakersfield include AIS Cancer Center at San Joaquin Community Hospital, California Retina Consultants, Michael G Oefelein Clinical Trials, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Bakersfield right now?
The largest active categories in Bakersfield are Cancer & tumors (27), Eye & vision (11), Vaccines (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.